Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.210
-0.010 (-0.45%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Equillium Employees
As of December 31, 2025, Equillium had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 20 or -57.14% compared to the previous year.
Employees
15
Change (1Y)
-20
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$1,200,600
Market Cap
140.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | -20 | -57.14% | 14 | 1 |
| Dec 31, 2024 | 35 | -9 | -20.45% | 35 | 0 |
| Sep 30, 2024 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2024 | 45 | -2 | -4.26% | 45 | 0 |
| Mar 31, 2024 | 44 | 7 | 18.92% | 44 | 0 |
| Dec 31, 2023 | 44 | 8 | 22.22% | 44 | 0 |
| Sep 30, 2023 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2023 | 47 | 2 | 4.44% | 47 | 0 |
| Mar 31, 2023 | 37 | -10 | -21.28% | 37 | 0 |
| Dec 31, 2022 | 36 | -9 | -20.00% | 36 | 0 |
| Sep 30, 2022 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2022 | 45 | - | - | 45 | 0 |
| Mar 31, 2022 | 47 | 16 | 51.61% | 47 | 0 |
| Dec 31, 2021 | 45 | 14 | 45.16% | 45 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Inovio Pharmaceuticals | 112 |
| Tenaya Therapeutics | 70 |
| OnKure Therapeutics | 45 |
| Biomea Fusion | 37 |
| Unicycive Therapeutics | 22 |
| TuHURA Biosciences | 22 |
| Tiziana Life Sciences | 10 |
EQ News
- 19 hours ago - Equillium management to meet with Piper Sandler - TheFly
- 3 days ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - Equillium reports Q2 EPS (4c), consensus (6c) - TheFly
- 22 days ago - Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 22 days ago - Equillium Earnings release: Q2 2026 - Filings
- 22 days ago - Equillium Quarterly report: Q2 2026 - Filings
- 23 days ago - Equillium Slides: Corporate presentation - Filings
- 6 weeks ago - Equillium initiated with a Buy at Clear Street - TheFly